Open AccessImpact of a pharmacist-led, mHealth-based intervention on tacrolimus trough variability in kidney transplant recipients: A report from the TRANSAFE Rx randomized controlled trial
Author(s) -
James N. Fleming,
Mulugeta Gebregziabher,
Aurora Posadas,
Zemin Su,
John W. McGillicuddy,
David J. Taber
Publication year - 2021
Publication title -
american journal of health-system pharmacy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.487
H-Index - 96
eISSN - 1535-2900
pISSN - 1079-2082
DOI - 10.1093/ajhp/zxab157
Subject(s) - tacrolimus , mhealth , pharmacist , kidney transplant , trough (economics) , medicine , randomized controlled trial , intervention (counseling) , trough level , kidney transplantation , family medicine , kidney , pharmacy , transplantation , nursing , psychological intervention , economics , macroeconomics
Nonadherence is a leading cause of death-censored allograft loss in kidney transplant recipients. Strong associations have tied tacrolimus intrapatient variability (IPV) to degree of nonadherence and high tacrolimus IPV to clinical endpoints such as rejection and allograft loss. Nonadherence is a dynamic, complex problem best targeted by multidimensional interventions, including mobile health (mHealth) technologies.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom